OQI member, Algorithmiq, wins a $2 million prize – a milestone for quantum computing and the community behind it

29th April 2026

Article by Marzena Lapka

Algorithmiq, a company developing advanced algorithms to solve complex problems in life sciences and a member of the Open Quantum Institute, has just won the $2 million Wellcome Leap Q4Bio prize for successfully demonstrating quantum computing’s potential in cancer drug discovery and development.

The Q4Bio challenge, designed and launched by an OQI advisor, brought together some of the world’s leading quantum teams – including OQI advisors, members and partners from QuEra, qBraid, IBM, Algorithmiq, University of Copenhagen, and Pasqal. Over the course of 2.5 years, their combined efforts have pushed the boundaries of quantum computing in biology, opening new possibilities for the entire scientific community to build on.

Classical computers have been simulating drug behaviour for decades. But for the most complex molecules – some that matter most in medicine – they reach their limits, forcing scientists to work with approximate answers. Algorithmiq has demonstrated in their project that quantum computers hold the potential to go further – charting a credible and rigorous path toward a future where quantum computers could meaningfully contribute to medicine beyond the reach of classical machines.

This milestone is a meaningful moment for the quantum community and a powerful signal of what becomes possible when talented, multidisciplinary teams unite around a shared goal. This is precisely the collaborative environment the Open Quantum Institute (OQI) is building – bringing together researchers, the private sector, diplomats, and philanthropy stakeholders from across the globe to advance the responsible development of quantum computing for the benefit of all.

One example of this collective work in action is the collaboration between Algorithmiq, Qatar University and CSL Behring, supported by OQI, to explore another medical application of quantum computing focused on drug metabolism design, asking why the same drug, prescribed at the same dose, affects patients so differently, sometimes with dangerous consequences. The reason medicine cannot yet answer this reliably is not a lack of data but a complexity that classical computers cannot resolve, and where quantum computing could make a difference.

Today, the Q4Bio challenge and Algorithmiq’s prize stand as a beacon for what quantum computing could unleash, not only for patients and for global health equity, but for a future where science serves humanity. It is also a strong testament to what OQI’s world-class community has the potential to unlock. The journey continues, and what quantum computing solutions could yet achieve remains an open and exciting question.

FURTHER READING:

Quantum computers take on health care – Nature article, 16 April 2026